loading
前日終値:
$18.35
開ける:
$18.47
24時間の取引高:
161
Relative Volume:
0.04
時価総額:
$442.21M
収益:
$1.70M
当期純損益:
$-47.01M
株価収益率:
-10.86
EPS:
-1.7
ネットキャッシュフロー:
$-157.28M
1週間 パフォーマンス:
-2.53%
1か月 パフォーマンス:
+4.58%
6か月 パフォーマンス:
-14.31%
1年 パフォーマンス:
-19.69%
1日の値動き範囲:
Value
$18.47
$18.47
1週間の範囲:
Value
$18.35
$18.89
52週間の値動き範囲:
Value
$17.00
$34.00

Puretech Health Plc Adr Stock (PRTC) Company Profile

Name
名前
Puretech Health Plc Adr
Name
セクター
Healthcare (1169)
Name
電話
-
Name
住所
-
Name
職員
90
Name
Twitter
Name
次回の収益日
2024-08-28
Name
最新のSEC提出書
Name
PRTC's Discussions on Twitter

PRTC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PRTC
Puretech Health Plc Adr
18.47 442.21M 1.70M -47.01M -157.28M -1.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-09-09 再開されました Leerink Partners Outperform

Puretech Health Plc Adr (PRTC) 最新ニュース

pulisher
Jan 28, 2025

Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Jan 28, 2025
pulisher
Jan 23, 2025

PureTech Health stock hits 52-week low at $16.81 amid market shifts By Investing.com - Investing.com South Africa

Jan 23, 2025
pulisher
Jan 23, 2025

PureTech Health stock hits 52-week low at $16.81 amid market shifts - Investing.com India

Jan 23, 2025
pulisher
Jan 09, 2025

FDA fast tracks PureTech's leukemia treatment - Investing.com

Jan 09, 2025
pulisher
Jan 08, 2025

PureTech to present at J.P. Morgan Healthcare Conference - Investing.com

Jan 08, 2025
pulisher
Dec 09, 2024

PureTech reports positive LYT-200 trial results in AML/MDS - Investing.com

Dec 09, 2024
pulisher
Sep 10, 2024

Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Sep 10, 2024
pulisher
Sep 01, 2024

South Korea Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research

Sep 01, 2024
pulisher
Aug 29, 2024

PureTech Health (LON:PRTC) Share Price Crosses Below 50-Day Moving Average of $175.96 - Defense World

Aug 29, 2024
pulisher
Aug 01, 2024

Asia Pacific Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research

Aug 01, 2024
pulisher
Jul 20, 2024

Europe Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research

Jul 20, 2024
pulisher
Jun 18, 2024

PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team - Business Wire

Jun 18, 2024
pulisher
May 20, 2024

PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - Yahoo Finance

May 20, 2024
pulisher
Mar 28, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 28, 2024
pulisher
Jan 02, 2024

The definitive Boston biotech layoff tracker for 2023 - The Business Journals

Jan 02, 2024
pulisher
Jan 11, 2022

Wall Street Analysts Predict an 82% Upside in PureTech Health PLC Sponsored ADR (PRTC): Here's What You Should Know - Nasdaq

Jan 11, 2022
pulisher
Jun 29, 2021

PureTech Announces Annual Results for Year Ended December 31, 2020 - Samoa Observer

Jun 29, 2021

Puretech Health Plc Adr (PRTC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):